The FYTIMRI brand, founded in 2013 (United States), from 496 sister brands and 17478 competing brands. FYTIMRI is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York FYTIMRI is part of the Drug Manufacturers activity sector.